Sionna Therapeutics, Inc. (SION)
NASDAQ: SION · Real-Time Price · USD
19.58
-0.19 (-0.94%)
Feb 24, 2025, 12:18 PM EST - Market open
Sionna Therapeutics Employees
Sionna Therapeutics had 28 employees as of December 31, 2023.
Employees
28
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,061,286
Market Cap
863.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
SION News
- 13 days ago - Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 16 days ago - U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO Week - Seeking Alpha
- 17 days ago - Sionna Therapeutics Prices Upsized Initial Public Offering - GlobeNewsWire
- 23 days ago - U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOs - Seeking Alpha
- 4 weeks ago - Sionna Therapeutics Seeks $100 Million in IPO For Cystic Fibrosis Treatments - Seeking Alpha
- 5 weeks ago - Cystic fibrosis biotech Sionna Therapeutics files for a $100 million IPO - Renaissance Capital
- 5 weeks ago - Sionna Therapeutics IPO Registration Document (S-1) - SEC